229 related articles for article (PubMed ID: 29760142)
21. In Vitro Effect of Porphyromonas gingivalis Methionine Gamma Lyase on Biofilm Composition and Oral Inflammatory Response.
Stephen AS; Millhouse E; Sherry L; Aduse-Opoku J; Culshaw S; Ramage G; Bradshaw DJ; Burnett GR; Allaker RP
PLoS One; 2016; 11(12):e0169157. PubMed ID: 28033374
[TBL] [Abstract][Full Text] [Related]
22. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
[TBL] [Abstract][Full Text] [Related]
23. Electrical enhancement of chlorhexidine efficacy against the periodontal pathogen Porphyromonas gingivalis within a biofilm.
Lasserre JF; Leprince JG; Toma S; Brecx MC
New Microbiol; 2015 Oct; 38(4):511-9. PubMed ID: 26571378
[TBL] [Abstract][Full Text] [Related]
24. New Application of Psoralen and Angelicin on Periodontitis With Anti-bacterial, Anti-inflammatory, and Osteogenesis Effects.
Li X; Yu C; Hu Y; Xia X; Liao Y; Zhang J; Chen H; Lu W; Zhou W; Song Z
Front Cell Infect Microbiol; 2018; 8():178. PubMed ID: 29922598
[TBL] [Abstract][Full Text] [Related]
25. Method for screening antimicrobial gels against multi-species oral biofilms.
Chathoth K; Martin B; Bonnaure-Mallet M; Baysse C
J Microbiol Methods; 2021 Aug; 187():106253. PubMed ID: 34087262
[TBL] [Abstract][Full Text] [Related]
26. An in vitro study of alginate oligomer therapies on oral biofilms.
Roberts JL; Khan S; Emanuel C; Powell LC; Pritchard MF; Onsøyen E; Myrvold R; Thomas DW; Hill KE
J Dent; 2013 Oct; 41(10):892-9. PubMed ID: 23907083
[TBL] [Abstract][Full Text] [Related]
27. Capsaicin inhibits Porphyromonas gingivalis growth, biofilm formation, gingivomucosal inflammatory cytokine secretion, and in vitro osteoclastogenesis.
Zhou Y; Guan X; Zhu W; Liu Z; Wang X; Yu H; Wang H
Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):211-9. PubMed ID: 23955115
[TBL] [Abstract][Full Text] [Related]
28. Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms.
Asahi Y; Noiri Y; Miura J; Maezono H; Yamaguchi M; Yamamoto R; Azakami H; Hayashi M; Ebisu S
J Appl Microbiol; 2014 May; 116(5):1164-71. PubMed ID: 24471579
[TBL] [Abstract][Full Text] [Related]
29. Effects of Japanese traditional herbal medicines (Kampo) on growth and virulence properties of Porphyromonas gingivalis and viability of oral epithelial cells.
Liao J; Zhao L; Yoshioka M; Hinode D; Grenier D
Pharm Biol; 2013 Dec; 51(12):1538-44. PubMed ID: 23987742
[TBL] [Abstract][Full Text] [Related]
30. In vivo and ex vivo actions of a novel P. gingivalis inhibitor on multi-species biofilm, inflammatory response, and periodontal bone loss.
Ho MH; Hasturk H; Young DF; Xie H
Mol Oral Microbiol; 2020 Oct; 35(5):193-201. PubMed ID: 32608190
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.
Wakabayashi H; Yamauchi K; Kobayashi T; Yaeshima T; Iwatsuki K; Yoshie H
Antimicrob Agents Chemother; 2009 Aug; 53(8):3308-16. PubMed ID: 19451301
[TBL] [Abstract][Full Text] [Related]
32. Black tea theaflavins attenuate Porphyromonas gingivalis virulence properties, modulate gingival keratinocyte tight junction integrity and exert anti-inflammatory activity.
Ben Lagha A; Grenier D
J Periodontal Res; 2017 Jun; 52(3):458-470. PubMed ID: 27549582
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
[TBL] [Abstract][Full Text] [Related]
34. Rapid Bactericidal Action of Propolis against Porphyromonas gingivalis.
Yoshimasu Y; Ikeda T; Sakai N; Yagi A; Hirayama S; Morinaga Y; Furukawa S; Nakao R
J Dent Res; 2018 Jul; 97(8):928-936. PubMed ID: 29494308
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Porphyromonas gingivalis biofilm by oxantel.
Dashper S; Ang CS; Liu SW; Paolini R; Veith P; Reynolds E
Antimicrob Agents Chemother; 2010 Mar; 54(3):1311-4. PubMed ID: 20038616
[TBL] [Abstract][Full Text] [Related]
36. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis.
Labrecque J; Bodet C; Chandad F; Grenier D
J Antimicrob Chemother; 2006 Aug; 58(2):439-43. PubMed ID: 16735419
[TBL] [Abstract][Full Text] [Related]
37. A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis.
Savage JR; Pulsipher A; Rao NV; Kennedy TP; Prestwich GD; Ryan ME; Lee WY
PLoS One; 2016; 11(6):e0157310. PubMed ID: 27308827
[TBL] [Abstract][Full Text] [Related]
38. Effects of dipeptide bestatin on Porphyromonas gingivalis and epithelial cells.
Labbé S; Grenier D; Plamondon P; Uitto VJ; Mayrand D
J Periodontol; 2001 Jun; 72(6):714-21. PubMed ID: 11453232
[TBL] [Abstract][Full Text] [Related]
39. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial activity of stable hemiaminals against Porphyromonas gingivalis.
Olczak T; Śmiga M; Kwiecień A; Bielecki M; Wróbel R; Olczak M; Ciunik Z
Anaerobe; 2017 Apr; 44():27-33. PubMed ID: 28104533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
